RecruitingNot Applicable

Treatment of Hypertrichosis With Intense Pulsed Light

Sweden39 participantsStarted 2023-12-01

Plain-language summary

The goal of this observational cohort study is to investigate the effect of intense pulsed light (IPL) for excessive hair in patients \>18 years of age and in need of gender affirmative treatment, refered to the department of dermatology and venereology, Umeå University Hospital, Sweden. The main questions this study aims to answer are: * \[To evaluate the effect of consecutive IPL treatments in women with hirsutism due to polycystic ovarial syndrome (PCOS), with or without anti-androgen treatment\] * \[To evaluate the effect of consecutive IPL treatments in individuals born as biologically men but in transition to become women, with or without hormonal treatment\]. Patients will use self-assessed questionnaires evaluating: * Background characteristics and time spend on concealing, reducing and treating hypertrichosis at home. * Ferriman-Gallwey scale, regarding the intensity of their hypertrichosis. * Dermatology Life Quality Index (DLQI) for quality of life Patients will be recruited consecutively and assessed at each visit, at the clinic before the treatments, ranging from baseline to a minimum of 5 treatment sessions.Since this is an observational study, all patients are treated by others than the researchers according to the routines och the clonic and there will be no other groups to compare the patients with.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years of age and above * Diagnosis of PCOS obtained by a gynaecologist and hirsutism, * Diagnosis of gender dysphoria obtained after psychiatric evaluation, * ≥3 points in hair density according to Ferriman-Gallwey scale on a specific part of the body Exclusion Criteria: * Language barrier causing problem in understanding questionnaires or not being able to give consent * Hair colours of white, orange or grey hair * Skin type 5 and above according to Fitzpatrick * Hereditary hypertrichosis

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

DLQI

Timeframe: 2023-2025

Trial details

NCT IDNCT05775328

SponsorAlexander Shayesteh

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2026-12-01

Contact for this trial

Alexander Shayesteh, MD., PhD

+46907852078 alexander.shayesteh@umu.se

View on ClinicalTrials.gov More Hypertrichosis trials